Hess, G., Hüttmann, A., Witzens‐Harig, M., Dreyling, M. H., Keller, U., Marks, R., Ernst, T., Pott, C., Viardot, A., Frontzek, F., Trautmann, M., Ruckes, C., Deuster, O., Rosenwald, A., Theobald, M., & Lenz, G. (2022). a phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. British journal of haematology, 198, 482–491. http://access.bl.uk/ark:/81055/vdc_100159762832.0x000064